SGRY Similar Chart Price Prediction
The price of SGRY is predicted to go up -24.59%, based on the high correlation periods with KELYB. The similarity of these two price pattern on the periods is 99.43%.
SGRY
KELYB
Down: -24.59%Similarity: 99.43%
SGRY Revenue Forecast
SGRY EPS Forecast
SGRY FAQs
What is bull’s view on SGRY?
What is bear's view on SGRY?
What is SGRY revenue forecast for next quarter？
What is SGRY eps forecast for next quarter？
SGRY Analyst's Forecast
Tao Qiu
Macquarie
Buy
2024-11-19
Price Target
$34
Upside
+45.36%
Macquarie notes that Surgery Partners has declined 31% in the past five trading sessions, with 14% of free-floating shares changing hands since Q3 earnings were reported. The firm's "theories" to explain the recent underperformance include disappointment at free cash flow and EPS downgrades, doubt over takeout prospects, anxiety over the RFK Jr. appointment, and high-yield related pressure, but it thinks "none of the concerns justifies the significant loss of equity value" when Surgery Partners' growth outlook and pipeline remain strong. Macquarie maintains an Outperform rating and $34 price target on the shares.
A.J. Rice
UBS
Strong Buy
2024-10-14
Price Target
$38
Upside
+19.69%
